Komori
bBreak Systems (3986) · InitiativeAdvanced

MA-EYES Feature Development, External System Integration and Next-Generation Platform Research

First written in FY2017. 25 of 34 entries say "Restated". Latest entry: FY2026.

34entries
10years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2020-Q3RestatedFY2022-Q2 – FY2024-Q32017: 22018: 420182019: 420192020: 420202021: 420212022: 320222023: 420232024: 320242025: 220252026: 42026
Same theme, other companies
Investment in the development of proprietary software products and IT servicesA theme 61 companies write about · 0 as a headwind · 62 as a tailwind

38 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 61 companies compared. The sentences above are computed from all 61.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥126 million. ・Expansion of existing functions and addition of new functions to the company's cloud ERP, MA-EYES ・対応 to changes in the external environment for the company's cloud ERP ・Implementation of new AI-powered functions in the company's cloud ERP」

    With research and development expenses of ¥126 million, the company is progressing with expanding existing MA-EYES functions, adding new functions,対応 to changes in the external environment and implementing new AI-powered functions.
  2. FY2026-H1RestatedAnnual report

    「The amount spent on research and development activities during the interim accounting period was ¥75 million. There were no material changes in the status of the company's research and development activities during the interim accounting period.」

    The company recorded ¥75 million for research and development activities, but stated that there were no material changes in activity levels.
  3. FY2025AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥132 million. ・Expansion of the functions of the company's cloud ERP, MA-EYES, and対応 to legal and regulatory amendments ・対応 to non-functional requirements, including security, for the company's cloud ERP ・Expansion of the service lineup for the SaaS version of the company's cloud ERP」

    Research and development expenses increased from ¥83 million in the previous fiscal year to ¥132 million, with work progressing on expanding MA-EYES functions,対応 to legal and regulatory amendments,対応 to non-functional requirements such as security, and expanding the SaaS service lineup.
  4. FY2025-H1RestatedAnnual report

    「The amount spent on research and development activities during the interim accounting period was ¥63 million. There were no material changes in the status of the company's research and development activities during the interim accounting period.」

    The company recorded ¥63 million for research and development activities, including MA-EYES feature development, but stated that there were no material changes in activity levels.
  5. FY2024AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥83 million. ・Expansion of the functions of the company's cloud ERP, MA-EYES, and対応 to legal and regulatory amendments ・Improvement of the user interface and performance of the company's cloud ERP ・Integration of the company's cloud ERP with third-party software」

    Research and development expenses were ¥83 million, with work progressing on expanding MA-EYES functions,対応 to legal and regulatory amendments, improving the UI and performance, and integrating with third-party software.
  6. FY2024-Q3RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the third quarter was ¥56 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the third quarter.」

    The company recorded ¥56 million for research and development activities, including MA-EYES feature development, but stated that there were no material changes in activity levels.
  7. FY2024-Q2RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the second quarter was ¥32 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the second quarter.」

    The company recorded ¥32 million for research and development activities, including MA-EYES feature development, but stated that there were no material changes in activity levels.
  8. FY2024-Q1RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the first quarter was ¥15 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the first quarter.」

    The company recorded ¥15 million in research and development activities, stating that there were no material changes in the status of those activities.
  9. FY2023RestatedAnnual report

    「During the fiscal year, as part of its research and development activities, the company conducted the following activities to establish competitive advantages for its products and services, with the head of the Development Division responsible and a development team of 15 to 26 Development Division employees: ・Expansion of the functions of the company's cloud ERP, MA-EYES, and対応 to legal and regulatory amendments ・Improvement of the user interface and performance of the company's cloud ERP ・Addition of new functions to the company's cloud ERP」

    The company continues to focus its research and development on expanding MA-EYES functions,対応 to legal and regulatory amendments, improving the UI and performance, and adding new functions.
  10. FY2023-Q3RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the third quarter was ¥61 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the third quarter.」

    The company recorded ¥61 million for research and development activities, including MA-EYES feature development and research into the technology platform for a next-generation cloud ERP, but stated that there were no material changes in activity levels.
  11. FY2023-Q2RestatedAnnual report

    「Research and development activities totaled ¥40 million in the first half. There were no material changes in the status of the company's research and development activities during the first half.」

    The company recorded ¥40 million for research and development activities, but stated that there were no material changes in activity levels.
  12. FY2023-Q1RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the first quarter was ¥22 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the first quarter.」

    The company recorded ¥22 million for research and development activities, including MA-EYES feature development and research into the technology platform for a next-generation cloud ERP, but stated that there were no material changes in activity levels.
  13. FY2022-Q3RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the third quarter was ¥68 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the third quarter.」

    The company recorded ¥68 million for research and development activities, including MA-EYES feature development and research into the technology platform for a next-generation cloud ERP, but stated that there were no material changes in activity levels.
  14. FY2022-Q2RestatedAnnual report

    「Research and development activities totaled ¥43 million in the first half. There were no material changes in the status of the company's research and development activities during the first half.」

    The company recorded research and development expenses of ¥43 million, but stated that there were no material changes in the status of research and development activities.
  15. FY2022-Q1AdvancedAnnual report

    「Research and development activities totaled ¥23 million in the first quarter. There were no material changes in the status of the company's research and development activities during the first quarter.」

    The company recorded research and development expenses of ¥23 million. While stating that there were no material changes in overall research and development activities, it also reported progress during the period, including completion of the core application for the next-generation MA-EYES.
  16. FY2021AdvancedAnnual report

    「・Expansion of the functions of the company's cloud ERP, MA-EYES ・Study, verification and development of the technology platform for a next-generation cloud ERP ・Migration (porting) of the application layer of a next-generation cloud ERP」

    With research and development expenses of ¥89 million, the company is progressing with the expansion of MA-EYES functions, development of the technology platform for a next-generation ERP and porting of its applications.
  17. FY2021-Q3RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the third quarter was ¥74 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the third quarter.」

    The company recorded ¥74 million for research and development activities, including MA-EYES feature development and research into the technology platform for a next-generation cloud ERP, and stated that there were no material changes.
  18. FY2021-Q2RestatedAnnual report

    「The amount spent on research and development activities during the cumulative period of the second quarter was ¥56 million. There were no material changes in the status of the company's research and development activities during the cumulative period of the second quarter.」

    The company recorded ¥56 million for research and development activities, including MA-EYES feature development and research into the technology platform for a next-generation cloud ERP, and stated that there were no material changes.
  19. FY2021-Q1RestatedAnnual report

    「Research and development expenditures for the three months ended 30 June were ¥32 million. There were no material changes in the status of the company's research and development activities during the three months ended 30 June.」

    Research and development expenses were ¥32 million in the first quarter, with no material changes in the status of research and development activities.
  20. FY2020AdvancedAnnual report

    「Total research and development expenses for the fiscal year were ¥63 million. During the fiscal year, as part of its research and development activities, the company conducted the following activities to establish competitive advantages for its products and services, with the head of the Development Division responsible and a development team of 12 to 33 Development Division employees: ・Expansion of the functions of the company's cloud ERP, MA-EYES ・Study and verification of the technology platform for a next-generation cloud ERP, and development of its platform modules ・Migration (porting) of the application layer of a next-generation cloud ERP」

    Research and development expenses increased to ¥63 million, with work progressing on expanding MA-EYES functions, developing platform modules for a next-generation ERP and porting its applications.
  21. FY2020-Q3RestatedAnnual report

    「Research and development activities totaled ¥37 million in the first nine months. There were no material changes in the status of the company's research and development activities during the first nine months.」

    Research and development expenses were ¥37 million in the first nine months, with no material changes in the status of research and development activities.
  22. FY2020-Q2RestatedAnnual report

    「Research and development activities totaled ¥25 million in the first half. There were no material changes in the status of the company's research and development activities during the first half.」

    Research and development expenses were ¥25 million in the first half, with no material changes in the status of research and development activities.
  23. FY2020-Q1RestatedAnnual report

    「Research and development activities totaled ¥11 million in the first quarter. There were no material changes in the status of the company's research and development activities during the first quarter.」

    Research and development expenses were ¥11 million in the first quarter, with no material changes in the status of research and development activities.
  24. FY2019RestatedAnnual report

    「Total research and development expenses for the fiscal year were ¥17 million.」

    The company recorded research and development expenses of ¥17 million and, with a development team of 3 to 10 Development Division employees, worked on expanding MA-EYES functions and studying and verifying the technology platform for a next-generation cloud ERP.
  25. FY2019-Q3RestatedAnnual report

    「Research and development activities during the cumulative third quarter amounted to ¥11 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」

    Research and development expenses were ¥11 million in the first nine months, with no material changes in the status of research and development activities.
  26. FY2019-Q2RestatedAnnual report

    「Research and development activities totaled ¥8 million in the first half. There were no material changes in the status of the company's research and development activities during the first half.」

    Research and development expenses were ¥8 million in the first half, with no material changes in the status of research and development activities.
  27. FY2019-Q1RestatedAnnual report

    「Research and development activities totaled ¥3 million in the first quarter. There were no material changes in the status of the company's research and development activities during the first quarter.」

    Research and development expenses were ¥3 million in the first quarter, with no material changes in the status of research and development activities.
  28. FY2018RestatedAnnual report

    「During the fiscal year, as part of its research and development activities, the company conducted the following activities to establish competitive advantages for its products and services, with the head of the Development Division responsible and a development team of 3 to 19 Development Division employees: ・Expansion of the functions of the company's cloud ERP, MA-EYES ・Study and verification of the technology platform for a next-generation cloud ERP」

    Research and development expenses were ¥21 million for the fiscal year, covering the expansion of MA-EYES functions and study and verification of the technology platform for a next-generation cloud ERP.
  29. FY2018-Q3RestatedAnnual report

    「Research and development activities totaled ¥21 million in the first nine months. There were no material changes in the status of the company's research and development activities during the first nine months.」

    Research and development expenses were ¥21 million in the first nine months, with no material changes in the status of research and development activities.
  30. FY2018-Q2RestatedAnnual report

    「Research and development activities totaled ¥18 million in the first half. There were no material changes in the status of the company's research and development activities during the first half.」

    Research and development expenses were ¥18 million in the first half, with no material changes in the status of research and development activities.
  31. FY2018-Q1RestatedAnnual report

    「Research and development activities totaled ¥13 million in the first quarter. There were no material changes in the status of the company's research and development activities during the first quarter.」

    Research and development expenses were ¥13 million in the first quarter, with no material changes in the status of research and development activities.
  32. FY2017First statedAnnual report

    「Total research and development expenses for the fiscal year were ¥52 million.」

    The company invested ¥52 million during the fiscal year in researching new reports, integration functions with external HR systems and the technology platform for a next-generation cloud ERP.
Moved together

"MA-EYES Functionality Expansion, Support for New Industries, and Technology Platform Upgrades" moved the same way as this thread, in the same document, in 5 of its 34 moves.

533332★123456
  1. ★This thread
  2. 1MA-EYES Functionality Expansion, Support for New Industries, and Technology Platform Upgrades5×
  3. 2Maintaining Stable Dividends While Retaining Internal Reserves3×
  4. 3Long-Term Stable Growth and Increased Corporate Value with an Emphasis on Revenue and Ordinary Profit3×
  5. 4Expansion of the System Integration Business by Leveraging Humalance, In-House Engineers and Existing Customers3×
  6. 5Investment in the Development of the Next-Generation Cloud ERP and Technology Infrastructure3×
  7. 6Business expansion centered on cloud ERP “MA-EYES”2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for bBreak Systems yet. It last moved in the General Meetings of Shareholders of 2026-09-01: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
MA-EYES Feature Development, External System Integration and Next-Generation Platform Research | bBreak Systems Company,Limited (3986) | Komori